title: EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European population.
authors: Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.
authors: Cesare
authors: C
authors: Gridelli
authors: Antonio
authors: A
authors: Rossi